Protein’eXpert

Founded in 2000 in Grenoble, France, Protein’eXpert has been offering contract research services focusing on the engineering and development of valuable and complex recombinant proteins.

Protein’eXpert has then extended its range of services to the biomanufacturing of therapeutic protein products for early clinical trials via its integrated subsidiary PX’Pharma in 2004. PX’Pharma has been providing dedicated contract services for process development & scale-up optimization, preclinical and clinical cGMP production.

Our partner Althea provides custom cGMP formulation, fill/finish, biologics filling and labeling in a wide range of sizes of vial and syringes. They have extensive experience working with recombinant proteins, small molecules, monoclonal antibodies, plasmid DNA and other pharmaceuticals and biologics. They offer flexible scheduling and fast turnaround times to meet your aggressive timelines for all your phase I, II, and III clinical requirements.

Is this your Organization?   Request Access

Locations


France
Grenoble, France
7, parvis Louis Néel
BP 50
Grenoble,
France, Europe

Contacts


CMOLocator

Production Lines

Grenoble, France   Small Scale
Location: Grenoble, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  MicrobialMicrobial
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  1L-100L100L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  NoneNone
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 22MAR10

Send Inquiry about this Production Line
Grenoble, France   Large Scale
Location: Grenoble, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  MicrobialMicrobial
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  100L-2000L1000L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  NoneNone
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 22MAR10

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.